JP5992309B2 - Composition for improving oral odor - Google Patents
Composition for improving oral odor Download PDFInfo
- Publication number
- JP5992309B2 JP5992309B2 JP2012266060A JP2012266060A JP5992309B2 JP 5992309 B2 JP5992309 B2 JP 5992309B2 JP 2012266060 A JP2012266060 A JP 2012266060A JP 2012266060 A JP2012266060 A JP 2012266060A JP 5992309 B2 JP5992309 B2 JP 5992309B2
- Authority
- JP
- Japan
- Prior art keywords
- odor
- composition
- improving
- oral
- hexenol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 40
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 claims description 35
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 claims description 21
- 229960001867 guaiacol Drugs 0.000 claims description 18
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 claims description 18
- JHEPBQHNVNUAFL-AATRIKPKSA-N (e)-hex-1-en-1-ol Chemical compound CCCC\C=C\O JHEPBQHNVNUAFL-AATRIKPKSA-N 0.000 claims description 15
- 230000032683 aging Effects 0.000 claims description 13
- 239000001278 2-(5-ethenyl-5-methyloxolan-2-yl)propan-2-ol Substances 0.000 claims description 10
- BRHDDEIRQPDPMG-UHFFFAOYSA-N Linalyl oxide Chemical compound CC(C)(O)C1CCC(C)(C=C)O1 BRHDDEIRQPDPMG-UHFFFAOYSA-N 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- 229940011037 anethole Drugs 0.000 claims description 9
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- 235000019645 odor Nutrition 0.000 description 45
- 208000035985 Body Odor Diseases 0.000 description 37
- 206010040904 Skin odour abnormal Diseases 0.000 description 34
- 230000000694 effects Effects 0.000 description 13
- 230000000873 masking effect Effects 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 206010006326 Breath odour Diseases 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 230000001953 sensory effect Effects 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- -1 pH adjusters Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000005068 transpiration Effects 0.000 description 4
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010016322 Feeling abnormal Diseases 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- UFLHIIWVXFIJGU-UHFFFAOYSA-N hex-3-en-1-ol Natural products CCC=CCCO UFLHIIWVXFIJGU-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000004014 plasticizer Substances 0.000 description 3
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 2
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 229930007744 linalool Natural products 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- BSAIUMLZVGUGKX-UHFFFAOYSA-N non-2-enal Chemical compound CCCCCCC=CC=O BSAIUMLZVGUGKX-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- CZCBTSFUTPZVKJ-UHFFFAOYSA-N rose oxide Chemical compound CC1CCOC(C=C(C)C)C1 CZCBTSFUTPZVKJ-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- UAQFADWTDBIBBZ-UHFFFAOYSA-N 2-[2-(2-naphthalen-2-ylethoxy)ethyl]naphthalene Chemical compound C1=CC=CC2=CC(CCOCCC=3C=C4C=CC=CC4=CC=3)=CC=C21 UAQFADWTDBIBBZ-UHFFFAOYSA-N 0.000 description 1
- IEMMBWWQXVXBEU-UHFFFAOYSA-N 2-acetylfuran Chemical compound CC(=O)C1=CC=CO1 IEMMBWWQXVXBEU-UHFFFAOYSA-N 0.000 description 1
- XSAYZAUNJMRRIR-UHFFFAOYSA-N 2-acetylnaphthalene Chemical compound C1=CC=CC2=CC(C(=O)C)=CC=C21 XSAYZAUNJMRRIR-UHFFFAOYSA-N 0.000 description 1
- LHGVFZTZFXWLCP-WBJZHHNVSA-N 2-methoxyphenol Chemical group CO[13C]1=[13CH][13CH]=[13CH][13CH]=[13C]1O LHGVFZTZFXWLCP-WBJZHHNVSA-N 0.000 description 1
- LVBXEMGDVWVTGY-SREVYHEPSA-N 2-octenal Chemical compound CCCCC\C=C/C=O LVBXEMGDVWVTGY-SREVYHEPSA-N 0.000 description 1
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- XMLSXPIVAXONDL-PLNGDYQASA-N Jasmone Chemical compound CC\C=C/CC1=C(C)CCC1=O XMLSXPIVAXONDL-PLNGDYQASA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940077731 carbohydrate nutrients Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 229940068682 chewable tablet Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000000550 effect on aging Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000008123 high-intensity sweetener Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 229940100688 oral solution Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 229930007790 rose oxide Natural products 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- LVBXEMGDVWVTGY-UHFFFAOYSA-N trans-2-octenal Natural products CCCCCC=CC=O LVBXEMGDVWVTGY-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
本発明は、経口体臭改善用組成物に関し、更に詳細には、経口摂取することで人の体臭を改善することのできる体臭改善用組成物およびこれを用いた体臭改善方法に関する。 The present invention relates to a composition for improving oral body odor, and more particularly to a composition for improving body odor that can improve human body odor by ingestion orally and a method for improving body odor using the same.
体臭は、体から放出される種々の揮発成分より構成されており、食生活、ストレス、加齢、各種疾患等の様々な状況において変化することが知られている。特に食生活と体臭の関係に関して、広く知られており、その代表的なものとしては、大蒜が挙げられる。 Body odor is composed of various volatile components released from the body, and is known to change in various situations such as diet, stress, aging, and various diseases. In particular, the relationship between eating habits and body odor is widely known, and a typical example is Oiso.
この体臭としては、人の汗の中に含まれる成分の臭い、皮膚からの分泌物の臭い、あるいはそれらの酸化物等に起因する臭い、腋臭、足臭、口臭、糞尿臭、加齢臭等が知られている。これらの臭いは人にとって不快な臭いと感じるため、これらの臭いを解消するための様々な対策がなされている(特許文献1〜3)。 This body odor includes the odor of ingredients contained in human sweat, the smell of secretions from the skin, or the odor caused by their oxides, foul odor, foot odor, halitosis, manure odor, aging odor, etc. It has been known. Since these odors feel unpleasant for humans, various measures have been taken to eliminate these odors (Patent Documents 1 to 3).
しかし、上記したように、体臭は、種々の臭い成分から構成される複合臭であり、様々な臭いに対応することは、非常に難しく、十分な対応がとれているとはいえない。 However, as described above, the body odor is a composite odor composed of various odor components, and it is very difficult to cope with various odors, and it cannot be said that sufficient measures are taken.
一方、体臭を改善させる漢方薬についても、医心方において古くから伝えられており、その代表的なものとしては、体身香が知られている。体身香は、芳香性の強い生薬からなっており、摂取することで体から香気を放出するようになり、体臭を改善させることができるといわれている。 On the other hand, Kampo medicines that improve body odor have also been reported for a long time in medical minds, and as a representative example, body aroma is known. The body fragrance is made of herbal medicine with strong fragrance, and it is said that when ingested, it releases fragrance from the body and can improve body odor.
また、バラの香りの代表成分である、リナロール、シトロネロールおよびゲラニオールに関しても、摂取することで、これら成分そのものが体から放出され(非特許文献1)、体臭を改善することができる。すなわち、摂取することで体から放出される物質は、体臭を改善させる効果を有する可能性があるといえる。 In addition, regarding linalool, citronellol and geraniol, which are representative components of the scent of roses, these components themselves are released from the body (Non-patent Document 1) and can improve body odor. That is, it can be said that a substance released from the body by ingestion may have an effect of improving body odor.
しかしながら、経口摂取により体表面から放出され、十分な効果をもって不快な体臭に対する消臭効果(以下「マスキング」という)や調和効果(以下「ハーモナージュ」という)を示す化合物ないし組成物は、これまでに知られていないのが実情であった。なお、本発明における「ハーモナージュ」とは、各種体臭の存在下であっても、体臭を含めた、におい全体として調和をとることができ、体臭の不快さを解消することを可能にする効果を意味する。 However, compounds or compositions that have been released from the body surface by oral ingestion and have a sufficient effect to exhibit an unpleasant body odor (hereinafter referred to as “masking”) and a harmony effect (hereinafter referred to as “harmonage”) have been used so far. The fact was not known. In addition, the “harmonage” in the present invention is an effect that makes it possible to harmonize the whole odor including body odor even in the presence of various body odors, and to eliminate the discomfort of body odors. Means.
本発明は、上記実情に鑑みなされたものである、その課題は、経口摂取することで、体臭を十分にマスキング及び/又はハーモナージュすることが可能である経口体臭改善用組成物を提供することである。 This invention is made | formed in view of the said situation, The subject is providing the composition for oral body odor improvement which can fully mask and / or harmonize body odor by ingesting orally. It is.
本発明者らは、上記課題を解決するために鋭意検討を行った結果、グアイアコールおよびヘキセノールを含む組成物を経口摂取することで、体臭を有効にマスキング及び/又はハーモナージュすることができることを見いだし、本発明を完成した。 As a result of intensive studies to solve the above problems, the present inventors have found that body odor can be effectively masked and / or harmonized by ingesting a composition containing guaiacol and hexenol. The present invention has been completed.
すなわち、本発明は、
(1)グアイアコールおよびヘキセノールを含有する経口体臭改善用組成物、
(2)さらにリナロールオキシド、アネトールおよびフェネチルアルコールから選ばれる化合物の少なくとも1種以上を含有する(1)に記載の経口体臭改善用組成物、
(3)食品及び医薬品である(1)または(2)に記載の経口体臭改善用組成物、
(4)体臭が加齢臭、口臭または足臭である(1)ないし(3)のいずれかに記載の経口体臭改善用組成物、
(5)グアイアコールおよびヘキセノールを含有する組成物を経口摂取することを特徴とする体臭の改善方法、
(6)グアイアコールおよびヘキセノールと、リナロールオキシド、アネトールおよびフェネチルアルコールから選ばれる化合物の少なくとも1種以上を含有する組成物を経口摂取することを特徴とする体臭の改善方法
である。
That is, the present invention
(1) A composition for improving oral odor containing guaiacol and hexenol,
(2) The composition for improving oral odor according to (1), further comprising at least one compound selected from linalool oxide, anethole and phenethyl alcohol,
(3) The composition for improving oral odor according to (1) or (2), which is a food and a medicine,
(4) The composition for improving oral odor according to any one of (1) to (3), wherein the body odor is an aging odor, halitosis or foot odor,
(5) A method for improving body odor characterized by orally ingesting a composition containing guaiacol and hexenol,
(6) A method for improving body odor characterized by orally ingesting a composition containing guaiacol and hexenol and at least one compound selected from linalool oxide, anethole and phenethyl alcohol.
本発明により、体臭を効果的に改善することが可能な経口体臭改善用組成物の提供が可能になった。 According to the present invention, it is possible to provide an oral body odor improving composition capable of effectively improving body odor.
本発明に使用される体臭改善成分の1つであるグアイアコールは、その一般名が2−メトキシフェノールである公知の化合物である。このものは、コーヒー、チョコレートなどに香料として使用されるものである。 Guaiacol, one of the body odor improving components used in the present invention, is a known compound whose general name is 2-methoxyphenol. This is used as a fragrance for coffee, chocolate, and the like.
また、他方の成分であるヘキセノールは、青葉アルコールとも呼ばれる不飽和アルコールの1つであり、青臭い特有の香気を有し、香水などの原料として利用されている公知化合物である。 The other component, hexenol, is one of unsaturated alcohols also called green leaf alcohols, is a known compound that has a characteristic odor of blue odor and is used as a raw material for perfumes and the like.
しかしながら、これらグアイアコールやヘキセノールを経口摂取することで、体表面から放出される物質が不快な体臭をマスキングないしハーモナージュすることに関しては、全く報告されていない。 However, there has been no report about the substances released from the body surface masking or harming unpleasant body odors by ingesting these guaiacol and hexenol.
本発明の経口体臭改善用組成物では、必須成分として、上記グアイアコールとヘキセノールを併用する。この組成物における、グアイアコールおよびヘキセノールの配合量は食品添加物公定書に記載された経口摂取の安全の範囲内であり、配合比も各成分が安全量の範囲にあれば特に限定されない。しかし、一般的なグアイアコールおよびヘキセノールの配合量は、全組成物中に対して、それぞれ0.001〜10質量%(以下、「%」で示す)であり、好ましくは0.005%〜5%、更に好ましくは0.01〜3%である。 In the composition for improving oral odor according to the present invention, the above-mentioned guaiacol and hexenol are used in combination as essential components. The blending amounts of guaiacol and hexenol in this composition are within the safe range of oral intake described in the Food Additives Official Document, and the blending ratio is not particularly limited as long as each component is within the safe range. However, the blending amounts of general guaiacol and hexenol are 0.001 to 10% by mass (hereinafter referred to as “%”), preferably 0.005% to 5%, based on the total composition. More preferably, it is 0.01 to 3%.
また、本発明は、グアイアコールおよびヘキセノールの必須体臭改善成分に、さらに必要に応じて、リナロールオキシド、アネトール、フェネチルアルコールから選ばれる化合物の少なくとも1種以上を併用することができる。これら併用される各成分は、何れも公知化合物である。 In the present invention, the essential body odor improving component of guaiacol and hexenol can be used in combination with at least one compound selected from linalool oxide, anethole, and phenethyl alcohol, if necessary. Each of these components used in combination is a known compound.
上記の、リナロールオキシド、アネトール、フェネチルアルコールを併用する場合、その配合量は、食品添加物公定書に記載された経口摂取の安全の範囲内であり、配合比も各成分が安全量の範囲にあれば特に限定されない。一般的なその配合量は、グアイアコールとヘキセノールの合計量100重量部に対して、各々0.00005〜5000重量部であり、好ましくは0.0005〜500重量部、更に好ましくは0.0016〜150重量部である。 When the above linalool oxide, anethole, and phenethyl alcohol are used in combination, the blending amount is within the safe range of oral intake described in the Food Additives Official Statement, and the blending ratio is within the safe amount range for each component. If there is no particular limitation. The general blending amount is 0.00005 to 5000 parts by weight, preferably 0.0005 to 500 parts by weight, and more preferably 0.0016 to 150 parts per 100 parts by weight of the total amount of guaiacol and hexenol. Parts by weight.
本発明の経口体臭改善用組成物は、上記グアイアコールとヘキセノールとを、あるいは、これらとリナロールオキシド等の併用成分とを、公知の経口医薬成分あるいは食品素材に配合し、常法に従って製剤化することにより、医薬品、医薬部外品または食品の形態で調製される。 The composition for improving oral odor of the present invention comprises the above-mentioned guaiacol and hexenol, or these and a combination component such as linalool oxide in a known oral pharmaceutical ingredient or food material, and is formulated according to a conventional method. To prepare in the form of a pharmaceutical, quasi-drug or food.
本発明の体臭改善用組成物において利用される経口医薬成分あるいは食品素材の例としては、賦形剤、pH調整剤、清涼化剤、懸濁化剤、消泡剤、粘稠剤、溶解補助剤、崩壊剤、結合剤、滑沢剤、抗酸化剤、コーティング剤、着色剤、矯味矯臭剤、界面活性剤、可塑剤等が挙げられ、これらは、発明の効果を損なわない質的および量的範囲で利用しうる。 Examples of oral pharmaceutical ingredients or food materials used in the body odor improving composition of the present invention include excipients, pH adjusters, cooling agents, suspending agents, antifoaming agents, thickeners, and dissolution aids. Agents, disintegrating agents, binders, lubricants, antioxidants, coating agents, coloring agents, flavoring agents, surfactants, plasticizers, etc., and these are qualitative and quantitative amounts that do not impair the effects of the invention. It can be used within the scope.
上記成分のうち、pH調整剤としては、有機及び無機の食用酸を用いることができる。酸はそれらの非解離形で、あるいはそれらの各塩、例えばクエン酸、リンゴ酸、フマル酸、アジピン酸、リン酸、グルコン酸、酒石酸、アスコルビン酸、酢酸、リン酸又はそれらの混合物を含めた食用有機酸である。また、重炭酸塩、リン酸水素カリウム又はナトリウム、リン酸二水素カリウム又はナトリウム等も用いることができる。 Among the above components, organic and inorganic edible acids can be used as the pH adjuster. Acids are in their undissociated form or include their respective salts such as citric acid, malic acid, fumaric acid, adipic acid, phosphoric acid, gluconic acid, tartaric acid, ascorbic acid, acetic acid, phosphoric acid or mixtures thereof It is an edible organic acid. Also, bicarbonate, potassium hydrogen phosphate or sodium, potassium dihydrogen phosphate or sodium, and the like can be used.
また、抗酸化剤としては、例えばビタミンC、ジブチルヒドロキシトルエン(BHT)、没食子酸プロピル、ブチルヒドロキシアニソール(BHA)、α−トコフェロール、クエン酸等、着色剤としては、例えばタール色素、酸化チタン等、界面活性剤としては、ポリグリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、モノステアリン酸ソルビタン、モノパルミチン酸ソルビタン、モノラウリン酸ソルビタン、ポリオキシエチレンポリオキシプロピレンブロックコポリマー、ポリソルベート類、ラウリル硫酸ナトリウム、マクロゴール類、ショ糖脂肪酸エステル等がそれぞれ挙げられる。 Examples of the antioxidant include vitamin C, dibutylhydroxytoluene (BHT), propyl gallate, butylhydroxyanisole (BHA), α-tocopherol, citric acid, and the like, and examples of the colorant include tar dye and titanium oxide. , Surfactants include polyglycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, sorbitan monostearate, sorbitan monopalmitate, sorbitan monolaurate, polyoxyethylene polyoxypropylene block copolymer, polysorbates, sodium lauryl sulfate, macro Examples thereof include galls and sucrose fatty acid esters.
また、本発明の経口体臭改善用組成物で利用される食品素材において、ミネラル類としては、ナトリウムイオンやカリウムイオン、カルシウム、クロム、銅、鉄、マグネシウム、マンガン、リン、セレン、ケイ素、モリブデンまたは亜鉛等が、嗜好性を高めるための甘味料としては、ステビア、スクラロース、アセスルファムカリウム、アスパルテーム等の高甘味度甘味料類、蔗糖等の炭水化物類、ソルビトール、エリスリトール、キシリトール等の糖アルコールや、グリセリン等のグリセロール類が、ビタミン類としては、ビタミンA、ビタミンB、ビタミンC、ビタミンD及びビタミンEもしくはそれらの各種誘導体、タウリン等がそれぞれ挙げられる。 Further, in the food material used in the composition for improving oral odor of the present invention, minerals include sodium ion, potassium ion, calcium, chromium, copper, iron, magnesium, manganese, phosphorus, selenium, silicon, molybdenum or As sweeteners for enhancing the palatability of zinc and the like, high-intensity sweeteners such as stevia, sucralose, acesulfame potassium and aspartame, carbohydrates such as sucrose, sugar alcohols such as sorbitol, erythritol and xylitol, glycerin Examples of vitamins include vitamin A, vitamin B, vitamin C, vitamin D and vitamin E, or various derivatives thereof, taurine and the like.
さらに、本発明の組成物には、各種化合物や香料等を添加しても良い。添加される化合物の例としては、1,8−シネオール、ローズオキシド、カルボン、メチル−β−ナフチルケトン、2−アセチルフラン、メントン、cis−ジャスモン、リナロール、α−テルピネオール、4−テルピネオール、リモネン、γ−テルピネン、ミルセン、p−シメン、テルピノレン、β-ナフチルエチルエーテル、オイゲノール、イソアミルアルコール、cis−3−ヘキセニルアルコール、フェニルエチルアルコール等が挙げられる。 Furthermore, you may add various compounds, a fragrance | flavor, etc. to the composition of this invention. Examples of the added compound include 1,8-cineole, rose oxide, carvone, methyl-β-naphthyl ketone, 2-acetylfuran, menthone, cis-jasmon, linalool, α-terpineol, 4-terpineol, limonene, Examples include γ-terpinene, myrcene, p-cymene, terpinolene, β-naphthylethyl ether, eugenol, isoamyl alcohol, cis-3-hexenyl alcohol, and phenylethyl alcohol.
本発明の経口体臭改善用組成物の好ましい形態は、医薬品または医薬部外品であり、その剤形としては、液剤、錠剤、顆粒剤、散剤、カプセル剤、ドライシロップ剤、チュアブル錠、経粘膜剤、腸溶性製剤等の経口用剤形を挙げることができる。 The preferred form of the composition for improving oral odor of the present invention is a pharmaceutical product or a quasi-drug, and its dosage form is a liquid, tablet, granule, powder, capsule, dry syrup, chewable tablet, transmucosal agent. And oral dosage forms such as enteric preparations.
例えば、経口体臭改善用組成物の形態が液剤であれば、抗酸化剤、着色剤、矯味矯臭剤、界面活性剤、可塑剤、pH調整剤などを混合し、常法により、ドライシロップ剤、液剤などの経口物とすることができる。また固形剤であれば、賦形剤、崩壊剤、結合剤、滑沢剤、抗酸化剤、コーティング剤、着色剤、矯味矯臭剤、界面活性剤、可塑剤などを混合し、常法により、顆粒剤、散剤、カプセル剤、錠剤などを製造することができる。 For example, if the form of the composition for improving oral odor is a liquid agent, an antioxidant, a coloring agent, a corrigent, a surfactant, a plasticizer, a pH adjuster, etc. are mixed, and a dry syrup agent and a liquid agent are mixed in a conventional manner. Orally. In the case of a solid agent, an excipient, a disintegrant, a binder, a lubricant, an antioxidant, a coating agent, a coloring agent, a flavoring agent, a surfactant, a plasticizer, and the like are mixed. Granules, powders, capsules, tablets and the like can be produced.
以上のようにして製造される本発明の体臭改善用組成物を用いて一日あたりに摂取されるグアイアコールおよびヘキセノールの量の範囲は、摂取者の年齢や、体臭の強さ等によっても相違するが、1日あたり、通常1mg〜10000mgであり、好ましくは、5mg〜5000mgであり、更に好ましくは10mg〜3000mgである。このような量となる経口体臭改善組成物を1回ないし数回に分けて摂取すればよい。 The range of the amount of guaiacol and hexenol consumed per day using the composition for improving body odor of the present invention produced as described above varies depending on the age of the user, the strength of body odor, etc. However, it is usually 1 mg to 10000 mg, preferably 5 mg to 5000 mg, more preferably 10 mg to 3000 mg per day. What is necessary is just to divide the oral body odor improving composition which becomes such an amount into 1 to several times.
同様に、併用する場合のリナロールオキシド、アネトール、フェネチルアルコールの量の範囲も、摂取者の年齢や、体臭の強さ等によっても相違するが、1日あたり、通常1mg〜10000mgであり、好ましくは、5mg〜5000mgであり、更に好ましくは10mg〜3000mgである。このような量となる経口体臭改善組成物を1回ないし数回に分けて摂取すればよい。 Similarly, the range of the amount of linalool oxide, anethole, and phenethyl alcohol when used in combination also varies depending on the age of the user, the intensity of body odor, etc., but is usually 1 mg to 10,000 mg per day, preferably It is 5 mg to 5000 mg, more preferably 10 mg to 3000 mg. What is necessary is just to divide the oral body odor improving composition which becomes such an amount into 1 to several times.
上記した量を経口より摂取することにより、香気成分が体表面から放出し、体臭をマスキング及び/又はハーモナージュし、消臭することができる。 By ingesting the above amount from the oral route, the aroma component is released from the body surface, and the body odor can be masked and / or harmonized and deodorized.
以下に実施例をあげ、本発明をさらに具体的に説明するが、本発明はこれに何ら制約されるものではない。 The present invention will be described more specifically with reference to the following examples. However, the present invention is not limited thereto.
実 施 例 1
体外蒸散性試験:
ペントバルビタール麻酔下のSD系雄性ラットに、グアイアコール、cis-3-ヘキセノール、リナロールオキシド、アネトール、フェネチルアルコールのそれぞれを、各1mL/kgの用量で十二指腸内に投与した。足底部を含む部位に容量10mLのガラスバイアルを装着し、3時間蒸散物を捕集した。また、この時、ガラスバイアルの温度を約40℃に保温した。
Example 1
In vitro transpiration test:
Guaiacol, cis-3-hexenol, linalool oxide, anethole, and phenethyl alcohol were each administered into the duodenum at a dose of 1 mL / kg to SD male rats under pentobarbital anesthesia. A glass vial with a capacity of 10 mL was attached to the site including the bottom of the foot, and the transpiration was collected for 3 hours. At this time, the temperature of the glass vial was kept at about 40 ° C.
捕集したガラスバイアル内の蒸散物は、1mLのエタノールにて回収し、0.45μmのフィルターにてろ過した後、サーモフィッシャーサイエンティフィック社製GC−MSシステム(TraceGC−PoralisQ)を用いて分析した。 The collected transpiration material in the glass vial was collected with 1 mL of ethanol, filtered through a 0.45 μm filter, and then analyzed using a GC-MS system (TraceGC-PoralisQ) manufactured by Thermo Fisher Scientific. did.
分析カラムにはDB−5ms(30m×0.25mm×0.25μm)を用い、キャリアガスには、ヘリウムガスを使用し、流量は1.2mL/minとした。オーブンの温度は50℃で1分間保持した後、毎分5分のペースで、180℃まで上昇させ、続いて、毎分20℃のペースで300℃まで上昇させ、5分間保持した。注入口の温度は250℃、イオン源の温度は230℃、トランスファーラインの温度は280℃とした。 DB-5 ms (30 m × 0.25 mm × 0.25 μm) was used for the analytical column, helium gas was used for the carrier gas, and the flow rate was 1.2 mL / min. The oven temperature was held at 50 ° C. for 1 minute, then increased to 180 ° C. at a rate of 5 minutes per minute, then increased to 300 ° C. at a rate of 20 ° C. per minute and held for 5 minutes. The inlet temperature was 250 ° C., the ion source temperature was 230 ° C., and the transfer line temperature was 280 ° C.
得られたクロマトグラムのピークのマススペクトルを解析した結果、回収した蒸散物中に投与した成分が含まれることを確認した。 As a result of analyzing the mass spectrum of the peak of the obtained chromatogram, it was confirmed that the collected components were contained in the collected transpiration product.
以上の結果、グアイアコール、cis−3−ヘキセノール、リナロールオキシド、アネトール、フェネチルアルコールは、摂取した後、成分そのものが、体表面から放出されることが明らかになった。 As a result, it has been clarified that after ingestion of guaiacol, cis-3-hexenol, linalool oxide, anethole, and phenethyl alcohol, the components themselves are released from the body surface.
実 施 例 2
消臭性試験1:
(1)表1に示す量のグアイアコール、cis-3-ヘキセノール、リナロールオキシド、アネトールおよびフェネチルアルコールを含む組成物1〜4及び比較組成物1〜2を作製した。
Example 2
Deodorization test 1:
(1) Compositions 1-4 and comparative compositions 1-2 containing guaiacol, cis-3-hexenol, linalool oxide, anethole and phenethyl alcohol in the amounts shown in Table 1 were prepared.
(2)上記(1)で調製した組成物1〜4及び比較組成物1〜2を容量約150cm3のバイアル内に添加し、さらに加齢臭モデルを0.1mL添加した。次いで、加齢臭モデルに対するマスキング及びハーモナージュ効果を以下の官能評価試験により検証した。その結果を表2に示した。 (2) The compositions 1-4 prepared in the above (1) and the comparative compositions 1-2 were added to a vial having a capacity of about 150 cm 3 , and 0.1 mL of an aging odor model was further added. Next, the masking and harmony effects on the aging odor model were verified by the following sensory evaluation test. The results are shown in Table 2.
( 加齢臭モデル )
成 分 質量(%)
ジブチルヒドロキシトルエン 1
ヘプタン酸 10
オクタン酸 10
ノネナール 0.2
オクテナール 0.03
トリエチルシトレート 78.77
(Aging odor model)
Component Mass (%)
Dibutylhydroxytoluene 1
Heptanoic acid 10
Octanoic acid 10
Nonenal 0.2
Octenal 0.03
Triethyl citrate 78.77
( マスキングの官能評価 )
マスキング効果は、次に示す5段階スコアにて評価を実施した。
1:非常に強く加齢臭を感じる
2:やや強く加齢臭を感じる
3:加齢臭を感じる
4:やや弱く加齢臭を感じる
5:加齢臭を感じない
(Sensory evaluation of masking)
The masking effect was evaluated with the following five-level score.
1: Very strong aging odor 2: Slightly aging odor 3: Aging odor 4: Slightly aging odor 5: No aging odor
( ハーモナージュの官能評価 )
ハーモナージュ効果は、次に示す5段階スコアにて評価を実施した。
2:調和されている
1:やや調和されている
0:どちらともいえない
−1:やや調和されていない
−2:調和されていない
(Sensory evaluation of harmony)
The harmony effect was evaluated using the following five-point score.
2: Harmonized 1: Slightly harmonized 0: Neither -1: Slightly harmonized -2: Not harmonized
< 加齢臭に対する効果 >
以上の結果、加齢臭モデルに対して、比較組成物1、2に比べ組成物1〜4が優れたマスキング効果及びハーモナージュ効果を示すことが明らかとなった。 As a result, it became clear that the compositions 1 to 4 showed superior masking effect and harmony effect compared to the comparative compositions 1 and 2 for the aging odor model.
実 施 例 3
実施例2の表1で示した組成物1〜4及び比較組成物1〜2を容量約10mLのバイアル内に添加し、さらに口臭モデルまたは足臭モデルが入ったバイアル内の空気1mLをシリンジを用いて添加した。次いで、口臭および足臭に対するマスキング及びハーモナージュ効果を以下の官能評価試験により検証した。その結果を表3及び表4に示した。
Example 3
Add compositions 1 to 4 and comparative compositions 1 to 2 shown in Table 1 of Example 2 into a vial having a capacity of about 10 mL, and further add 1 mL of air in the vial containing the bad breath model or foot odor model to a syringe. Added. Next, masking and harmony effects on bad breath and foot odor were verified by the following sensory evaluation test. The results are shown in Tables 3 and 4.
( 口臭モデル )
容量約10mLのバイアルに2−メルカプトエタノール100μLを添加した。
( 足臭モデル )
容量約10mLのバイアルにイソ吉相酸100μLを添加した。
(Bad breath model)
To a vial of about 10 mL capacity, 100 μL of 2-mercaptoethanol was added.
(Foot odor model)
To a vial with a volume of about 10 mL was added 100 μL of iso-amino acid.
( マスキングの官能評価 )
マスキング効果は、次に示す5段階スコアにて評価を実施した。
1:非常に強く口臭または足臭を感じる
2:やや強く口臭または足臭を感じる
3:口臭または足臭を感じる
4:やや弱く口臭または足臭を感じる
5:口臭または足臭を感じない
(Sensory evaluation of masking)
The masking effect was evaluated with the following five-level score.
1: Feels bad breath or foot odor very strongly 2: Feels bad breath or foot odor 3: Feels bad breath or foot odor 4: Feels weak or bad foot odor 5: Does not feel bad breath or foot odor
( ハーモナージュの官能評価 )
ハーモナージュ効果は、次に示す5段階スコアにて評価を実施した。
2:調和されている
1:やや調和されている
0:どちらともいえない
−1:やや調和されていない
−2:調和されていない
(Sensory evaluation of harmony)
The harmony effect was evaluated using the following five-point score.
2: Harmonized 1: Slightly harmonized 0: Neither -1: Slightly harmonized -2: Not harmonized
< 口臭モデルに対する効果 >
< 足臭モデルに対する効果 >
以上の結果、口臭及び足臭モデルに対して、比較組成物1、2に比べ組成物1〜4が優れたマスキング効果及びハーモナージュ効果を示すことが明らかとなった。 As a result, it became clear that the compositions 1 to 4 showed superior masking effect and harmony effect compared to the comparative compositions 1 and 2 for the bad breath and foot odor models.
処 方 例 1
内服液剤の調製:
下記表5に記載の成分を全量の15%の水に溶解し、十分に攪拌した。次に、クエン酸、クエン酸ナトリウムにてpHを3.0に調整し、全量の25%の濃度の飲料原液を調製した。最後にこの飲料原液に精製水を加えて全量とし、100mlのガラス瓶に充填し、内服液剤を得た。この内服液剤は、体臭の改善が可能であり、服用性が良好なものであった。
Treatment example 1
Preparation of oral solution:
The components listed in Table 5 below were dissolved in 15% of the total amount of water and stirred thoroughly. Next, the pH was adjusted to 3.0 with citric acid and sodium citrate, and a beverage stock solution having a concentration of 25% of the total amount was prepared. Finally, purified water was added to the beverage stock solution to make a total amount, and the solution was filled in a 100 ml glass bottle to obtain an internal solution. This internal liquid solution was able to improve body odor and had good dosing properties.
本発明組成物は、これを経口摂取することで、体臭をマスキング及び/又はハーモナージュすることが可能となり、体臭を効果的に改善し、不快な体臭を有効に低減させることができる。 The composition of the present invention can be masked and / or harmonized by ingesting it, effectively improving body odor and effectively reducing unpleasant body odor.
Claims (3)
The composition according to claim 1 or 2, which is a food or a medicine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012266060A JP5992309B2 (en) | 2011-12-13 | 2012-12-05 | Composition for improving oral odor |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011271962 | 2011-12-13 | ||
JP2011271962 | 2011-12-13 | ||
JP2012266060A JP5992309B2 (en) | 2011-12-13 | 2012-12-05 | Composition for improving oral odor |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013144669A JP2013144669A (en) | 2013-07-25 |
JP5992309B2 true JP5992309B2 (en) | 2016-09-14 |
Family
ID=49040695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012266060A Active JP5992309B2 (en) | 2011-12-13 | 2012-12-05 | Composition for improving oral odor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5992309B2 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63266A (en) * | 1986-06-19 | 1988-01-05 | Takasago Corp | Method for improving animal smell |
JP3665360B2 (en) * | 1994-05-02 | 2005-06-29 | ポーラ化成工業株式会社 | Active oxygen scavenger and composition containing the same |
JP2003113392A (en) * | 2001-10-04 | 2003-04-18 | Kiyomitsu Kawasaki | Perfuming/deodorizing composition and perfuming/ deodorizing agent for human body containing the perfuming/deodorizing composition |
JP5708173B2 (en) * | 2010-04-16 | 2015-04-30 | 大正製薬株式会社 | Evaluation method for body odor improving substances |
-
2012
- 2012-12-05 JP JP2012266060A patent/JP5992309B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2013144669A (en) | 2013-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20060022668A (en) | Compositions and foods and drinks contiaing higher fatty acid derivative | |
JP5839681B2 (en) | Liquid composition containing herbal extract | |
JP5846350B2 (en) | Bone disease prevention or treatment composition | |
TWI659748B (en) | Oral composition | |
JP5992305B2 (en) | Composition for improving oral odor | |
JP4889948B2 (en) | An oral solution with excellent ingestion | |
JP5992307B2 (en) | Composition for improving oral odor | |
JP5992304B2 (en) | Oral body odor improving composition | |
JP5992309B2 (en) | Composition for improving oral odor | |
JPH10245343A (en) | Oral composition for improving body small | |
JP5083492B2 (en) | Liquid for internal use | |
JP5992308B2 (en) | Oral body odor improving composition | |
JP5543656B1 (en) | Composition containing useful ingredients in turmeric | |
JP5543655B1 (en) | Beverages that stably contain useful ingredients in turmeric | |
JP5992306B2 (en) | Oral body odor improving composition | |
JP2003095905A (en) | Deodorant for oral cavity | |
JP5576621B2 (en) | Body odor suppressor for internal use | |
JP5980292B2 (en) | β-secretase inhibitor and acetylcholinesterase inhibitor | |
JP4865905B1 (en) | Deodorant composition | |
JP3656972B2 (en) | Alcohol smell reducing agent | |
WO2017051585A1 (en) | Inhaling fragrance, perfume, and food flavoring | |
JPH1135439A (en) | Deodorant and its production | |
JP2008029221A (en) | Novel food deodorant, and food deodorant-added food | |
JP2013010799A (en) | Oral composition | |
JP2016094378A (en) | Composition for suppressing mouth odors containing myrsine seguinii h. lev. extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150723 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160510 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160706 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160809 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160817 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5992309 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |